Evidence map›Paper›PMID 26199067›Full record

ArticleBMC complementary and alternative medicine2015

Pre-administration of turmeric prevents methotrexate-induced liver toxicity and oxidative stress.

Adel Rezaei Moghadam, Soheil Tutunchi, Ali Namvaran-Abbas-Abad, Mina Yazdi, Fatemeh Bonyadi, Daryoush Mohajeri, Mohammad Mazani, Hassan Marzban, Marek J Łos, Saeid Ghavami

Open access · goldAbstract read
In one paragraph

Article in BMC complementary and alternative medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
6.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 116 citations in OpenAlex.

  1. Experimental evaluation ofExperimental and therapeutic medicine · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Life (Basel, Switzerland) · 2023
    Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 8 institutions in 3 countries.

Adel Rezaei MoghadamFaculty of Veterinary Medicine, Tabriz Branch, Islamic Azad University, Tabriz, Iran. armoghadm@hotmail.com.
Soheil TutunchiFaculty of Veterinary Medicine, Tabriz Branch, Islamic Azad University, Tabriz, Iran. soheyl_7@yahoo.com.
Ali Namvaran-Abbas-AbadYoung Researchers and Elite club, Tabriz Branch, Islamic Azad University, Tabriz, Iran, Shiraz, Iran. dr.namvran@gmail.com.
Mina YazdiFaculty of Veterinary Medicine, Tehran University, Tehran, Iran. Mina.Yazdi@gmail.com.
Fatemeh BonyadiFaculty of Medicine, Tehran Branch, Islamic Azad University, Tehran, Iran. f.bonyadi86@gmail.com.
Daryoush MohajeriDepartment of Pathobiology, Tabriz Branch, Islamic Azad University, Islamic Azad University, Tabriz, Iran. daryoushmohajeri@yahoo.com.
Mohammad MazaniDepartment of Biochemistry, Ardabil University of Medical Science, Ardabil, Iran. m.mazani@arums.ac.ir.
Hassan MarzbanDepartment of Human Anatomy and Cell Science, College of Medicine, Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada. hassan.marzban@med.umanitoba.ca.
Marek J ŁosDepartment of Clinical and Experimental Medicine (IKE), Division of Cell Biology, and Integrative Regenerative Medicine Center (IGEN), Linköping University, Linköping, Sweden. marek.los@liu.se.
Saeid GhavamiDepartment of Human Anatomy and Cell Science, College of Medicine, Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada. saeid.Ghavami@gmail.com.
Islamic Azad University of Tabriz · IRArdabil University of Medical Sciences · IRChildren's Hospital Research Institute of Manitoba · CAIslamic Azad University Medical Branch of Tehran · IRIslamic Azad University of Shiraz · IRLinköping University · SEUniversity of Manitoba · CAUniversity of Tehran · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMethotrexate (MTX) is an antimetabolite broadly used in treatment of cancer and autoimmune diseases. MTX-induced hepatotoxicity limits its application. We investigated hepatoprotective effects of turmeric in MTX-induced liver toxicity.

methodsAll experiments were performed on male Wistar albino rats that were randomly divided into six groups. Group one received saline orally for 30 days (control group), groups two and three received turmeric extract (100, 200 mg/kg respectively) orally for 30 days, group four received single dose, of MTX IP at day 30, groups five and six received turmeric extract 100 and 200 mg/kg orally respectively for 30 days and single dose of methoterxate IP (20 mg/kg) at day 30. Four days after MTX injection animals were sacrificed and evaluated. Blood ALT and AST (indicators of hepatocyte injury), ALP and bilirubin (markers of biliary function), albumin (reflect liver synthetic function) as well as the plasma TAS concentration (antioxidant defenses) were determined. The cellular antioxidant defense activities were examined in liver tissue samples using SOD, CAT, and GSH-Px for the oxidative stress, and MDA for lipid peroxidation. In addition, liver damage was evaluated histopathologically.

resultsMTX significantly induced liver damage (P<0.05) and decreased its antioxidant capacity, while turmeric was hepatoprotective. Liver tissue microscopic evaluation showed that MTX treatment induced severe centrilobular and periportal degeneration, hyperemia of portal vein, increased artery inflammatory cells infiltration and necrosis, while all of histopathological changes were attenuated by turmeric (200 mg/kg).

conclusionTurmeric extract can successfully attenuate MTX-hepatotoxicity. The effect is partly mediated through extract's antinflammatory activity.

Indexed as

Chemical and Drug Induced Liver InjuryAnimalsCurcumaLiverMaleMethotrexateOxidative StressPlant ExtractsProtective AgentsRatsRats, WistarMethotrexatePlant ExtractsProtective Agentsturmeric extract

Identifiers

PMID26199067
PMCPMC4511036
OpenAlexW1508021342

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.